User profiles for Pavel Novikov
Pavel NovikovAvid Technology, Inc. | Boston, MA Verified email at avid.com Cited by 395 |
[HTML][HTML] Revised 2017 international consensus on testing of ANCAs in granulomatosis with polyangiitis and microscopic polyangiitis
…, CGM Kallenberg, S Moiseev, P Novikov… - Nature Reviews …, 2017 - nature.com
Anti-neutrophil cytoplasmic antibodies (ANCAs) are valuable laboratory markers used for
the diagnosis of well-defined types of small-vessel vasculitis, including granulomatosis with …
the diagnosis of well-defined types of small-vessel vasculitis, including granulomatosis with …
Mepolizumab for eosinophilic granulomatosis with polyangiitis: a European multicenter observational study
…, T Neumann, G Lopalco, P Novikov… - Arthritis & …, 2022 - Wiley Online Library
Objective Mepolizumab proved to be an efficacious treatment for eosinophilic granulomatosis
with polyangiitis (EGPA) at a dose of 300 mg every 4 weeks in the randomized, controlled …
with polyangiitis (EGPA) at a dose of 300 mg every 4 weeks in the randomized, controlled …
Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: a prospective cohort study
…, Y Braun-Moscovici, F Iannone, PI Novikov… - Annals of the …, 2019 - ard.bmj.com
Objective To assess the safety and efficacy of rituximab in systemic sclerosis (SSc) in clinical
practice. Methods We performed a prospective study including patients with SSc from the …
practice. Methods We performed a prospective study including patients with SSc from the …
2020 international consensus on ANCA testing beyond systemic vasculitis
This document follows up on a 2017 revised international consensus on anti-neutrophil
cytoplasm antibodies (ANCA) testing in granulomatosis with polyangiitis and microscopic …
cytoplasm antibodies (ANCA) testing in granulomatosis with polyangiitis and microscopic …
End-stage renal disease in ANCA-associated vasculitis
S Moiseev, P Novikov, D Jayne… - Nephrology Dialysis …, 2017 - academic.oup.com
The outcomes in patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated
vasculitis have improved significantly over the past decades, although a significant proportion of …
vasculitis have improved significantly over the past decades, although a significant proportion of …
Brief Report: Rituximab for the Treatment of Adult‐Onset IgA Vasculitis (Henoch‐Schönlein)
…, P Eriksson, M Segelmark, P Novikov… - Arthritis & …, 2018 - Wiley Online Library
Objective Adult‐onset IgA vasculitis (Henoch‐Schönlein) (Ig AV ) is a rare systemic
vasculitis characterized by IgA1‐dominant deposits. The treatment of adult‐onset Ig AV is …
vasculitis characterized by IgA1‐dominant deposits. The treatment of adult‐onset Ig AV is …
Efficacy and safety of TNF-α antagonists and tocilizumab in Takayasu arteritis: multicentre retrospective study of 209 patients
A Mekinian, L Biard, L Dagna, P Novikov… - …, 2022 - academic.oup.com
Objective To assess the safety and the efficacy of TNF-α antagonists and tocilizumab in
patients with Takayasu arteritis (TAK). Methods A total of 209 patients with TAK [median age 29 …
patients with Takayasu arteritis (TAK). Methods A total of 209 patients with TAK [median age 29 …
International consensus on antineutrophil cytoplasm antibodies testing in eosinophilic granulomatosis with polyangiitis
…, AJ Mohammad, F Moosig, P Novikov… - American journal of …, 2020 - atsjournals.org
An international consensus on antineutrophil cytoplasm antibodies (ANCA) testing in
eosinophilic granulomatosis with polyangiitis (EGPA) is presented. ANCA, specific for …
eosinophilic granulomatosis with polyangiitis (EGPA) is presented. ANCA, specific for …
The alternative complement pathway in ANCA-associated vasculitis: further evidence and a meta-analysis
…, A Zykova, N Bulanov, P Novikov… - Clinical & …, 2020 - academic.oup.com
We compared the common pathway components C3a, C5a and membrane attack complex (MAC),
also known as C5b-9, and the alternative pathway components factor B and …
also known as C5b-9, and the alternative pathway components factor B and …
Accuracy and precision of navigated transcranial magnetic stimulation
Objective. Transcranial magnetic stimulation (TMS) induces an electric field (E-field) in the
cortex. To facilitate stimulation targeting, image-guided neuronavigation systems have been …
cortex. To facilitate stimulation targeting, image-guided neuronavigation systems have been …